These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 2925206)

  • 41. Estimation of heterokaryon formation and hybridoma growth in murine and human cell fusions.
    Alkan SS; Mestel F; Jiricka J; Blaser K
    Hybridoma; 1987 Aug; 6(4):371-9. PubMed ID: 3623581
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Production of monoclonal antibodies.
    Yokoyama WM
    Curr Protoc Cell Biol; 2001 May; Chapter 16():Unit 16.1. PubMed ID: 18228333
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of electric-field-mediated cell fusion to produce hybridomas secreting monoclonal antibodies.
    Zhao X
    Methods Mol Biol; 1995; 45():61-7. PubMed ID: 7550693
    [No Abstract]   [Full Text] [Related]  

  • 44. Preparation of human-mouse heterohybridomas against an immunising antigen.
    Jessup CF; Baxendale H; Goldblatt D; Zola H
    J Immunol Methods; 2000 Dec; 246(1-2):187-202. PubMed ID: 11121559
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A short-duration polyethylene glycol fusion technique for increasing production of monoclonal antibody-secreting hybridomas.
    Lane RD
    J Immunol Methods; 1985 Aug; 81(2):223-8. PubMed ID: 4020150
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased frequency of both total and specific monoclonal antibody producing hybridomas using a fusion partner that constitutively expresses recombinant IL-6.
    Harris JF; Hawley RG; Hawley TS; Crawford-Sharpe GC
    J Immunol Methods; 1992 Apr; 148(1-2):199-207. PubMed ID: 1373425
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hybridoma generation by in vitro immunization of murine splenocytes with cytosolic proteins of Chinese hamster ovary (CHO) mitotic cells.
    Ravi M; Sundar SS; Kumar KK; Parvathi D; Paul SF
    Hybridoma (Larchmt); 2007 Oct; 26(5):311-5. PubMed ID: 17979547
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of three human-murine heteromyeloma cell lines for formation of human hybridomas after electrofusion with human peripheral blood lymphocytes from meningococcal cases and carriers.
    Delvig AA; Koumaré B; Glaser RW; Wang JF; Jahn S; Achtman M
    Hum Antibodies Hybridomas; 1995; 6(2):42-6. PubMed ID: 7492749
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Generation of murine monoclonal antibodies in serum-free medium.
    Liu RS; Ta D; Payne J; Coccia M; Kuus-Reichel K
    Hybridoma; 1998 Feb; 17(1):69-72. PubMed ID: 9523240
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The use of an anti-CD40 agonist monoclonal antibody during immunizations enhances hybridoma generation.
    Rycyzyn MA; Staquet K; Fisher J; Bannish G; Bassiri A; Duchala C; Giles-Komar J
    Hybridoma (Larchmt); 2008 Feb; 27(1):25-30. PubMed ID: 18294073
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development and characterization of mouse hybridomas.
    Mechetner E
    Methods Mol Biol; 2007; 378():1-13. PubMed ID: 18605074
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High efficiency creation of human monoclonal antibody-producing hybridomas.
    Dessain SK; Adekar SP; Stevens JB; Carpenter KA; Skorski ML; Barnoski BL; Goldsby RA; Weinberg RA
    J Immunol Methods; 2004 Aug; 291(1-2):109-22. PubMed ID: 15345310
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The construction and use of a human-mouse myeloma analogue suitable for the routine production of hybridomas secreting human monoclonal antibodies.
    Posner MR; Elboim H; Santos D
    Hybridoma; 1987 Dec; 6(6):611-25. PubMed ID: 3436625
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development of mouse hybridomas by fusion of myeloma cells with lymphocytes derived from spleen, lymph node, and bone marrow.
    Başalp A; Yücel F
    Hybrid Hybridomics; 2003 Oct; 22(5):329-31. PubMed ID: 14678651
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Modifications of hybridoma technology which improve the yield of monoclonal antibody producing cells.
    Orlik O; Altaner C
    J Immunol Methods; 1988 Nov; 115(1):55-9. PubMed ID: 2848072
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Electrofused mammalian cells analyzed by free-flow electrophoresis.
    Kowalski M; Hannig K; Klöck G; Gessner P; Zimmermann U; Neil GA; Sammons DW
    Biotechniques; 1990 Sep; 9(3):322-41. PubMed ID: 2223074
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An extreme strategy for the production of hybridoma.
    Golestani R; Pourfathollah AA; Moazzeni SM
    Hybridoma (Larchmt); 2009 Apr; 28(2):139-44. PubMed ID: 19249989
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Preparation of mouse monoclonal antibody against human vasorin (VASN) protein by high-efficacy electrofusion-based protocol].
    Yin M; Nie Y; Liu H; Zhang S; Liu L; Li X; Wang H
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2021 Mar; 37(3):265-270. PubMed ID: 33766234
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Specific bovine monoclonal antibody produced by a re-fused mouse/calf hybridoma.
    Tucker EM; Dain AR; Clarke SW; Donker RA
    Hybridoma; 1984; 3(2):171-6. PubMed ID: 6480023
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of postfusion cell density on establishment of hybridomas.
    Kontseková E; Novák M; Kontsek P; Borecký L; Lesso J
    Folia Biol (Praha); 1988; 34(1):18-22. PubMed ID: 3391325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.